Publicacións nas que colabora con Federico Martinón Torres (8)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  3. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2022

  1. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity

    Environmental Research, Vol. 210

  2. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients

    Scientific Reports, Vol. 12, Núm. 1

2018

  1. Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform

    Anales de Pediatria, Vol. 89, Núm. 5, pp. 314.e1-314.e6

2014

  1. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 80, Núm. 4, pp. 259-260

  2. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes

    Revista Pediatría de Atención Primaria, Vol. 16, Núm. 62, pp. 108